Clinical trials
Terminated Myositis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| IGM Biosciences, Inc. | 1 |
| Johns Hopkins University | 1 |
| Louisiana State University Health Sciences Center Shreveport | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 10 |
| Arthritis, Rheumatoid | 3 |
| Polymyositis | 3 |
| Dermatomyositis | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Muscle Weakness | 2 |
| Myositis, Inclusion Body | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Arthritis | 1 |
| Deglutition Disorders | 1 |
Trials
Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.